SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058237
Filing Date
2023-11-02
Accepted
2023-11-02 16:17:01
Documents
55
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlay-20230930.htm   iXBRL 10-Q 2661793
2 EX-10.1 rlay-ex10_1.htm EX-10.1 23741
3 EX-31.1 rlay-ex31_1.htm EX-31.1 18727
4 EX-31.2 rlay-ex31_2.htm EX-31.2 18491
5 EX-32.1 rlay-ex32_1.htm EX-32.1 17031
  Complete submission text file 0000950170-23-058237.txt   8506193

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20230930_pre.xml EX-101.PRE 322727
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20230930.xsd EX-101.SCH 57460
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlay-20230930_cal.xml EX-101.CAL 48753
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlay-20230930_def.xml EX-101.DEF 204503
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20230930_lab.xml EX-101.LAB 439872
49 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20230930_htm.xml XML 1464926
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 231372553
SIC: 2836 Biological Products, (No Diagnostic Substances)